News
SNMMI 2025, post-177Lu therapy, WB SPECT/CT, WB SPECT/CT Studies Post Lu 177 Therapy, 177Lu-PSMA SPECT, StarGuide scanner, 177Lu-PSMA-617 radiopharmaceutical therapy.
(UroToday.com) The Bladder Cancer Advocacy Network (BCAN) Bladder Cancer Think Tank 2025, held in Washington D.C., United States, was host to the session: Navigating Financial Toxicity in Bladder ...
PSMA and Beyond 2025 antibody drug development (ADC) in prostate cancer, ADC program in advance prostate cancer, PSMA expression, ...
(UroToday.com) The Bladder Cancer Advocacy Network (BCAN) Bladder Cancer Think Tank 2025, held in Washington D.C., United States, was host to the session: BCAN 2023 Bladder Cancer Research Innovation ...
BCAN 2025 EA8192 for upper tract urothelial carcinoma (UTUC), ECOG-ACRIN 8141 trial, accelerated MVAC with durvalumab, gemcitabine plus durvalumab, neoadjuvant chemotherapy, POUT trial.
(UroToday.com) The Bladder Cancer Advocacy Network (BCAN) Bladder Cancer Think Tank 2025 held in Washington, D.C., United States, between July 30 th and August 1 st. was host to the Session: Lessons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback